TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15098212

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stop test (mechanical interruption)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pressure-flow studies (Schäfer contractility nomogram)
Number of subjects: 0
Study: 12413620

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 800 microg
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 800 microg
Number of subjects: 1011
Study: 9848486

Group type: COMPARATOR
Intervention: HVB bisacodyl suppositories
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PGB bisacodyl suppositories
Number of subjects: 14
Study: 8029808

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 3141866

Group type: EXPERIMENTAL
Intervention: Intracutaneous provocative‐neutralization food test interpreted by skin response (IPFT SK)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intracutaneous provocative‐neutralization food test interpreted by symptom provocation (IPFT PR)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Double-blind IPFT results
Number of subjects: 37
Study: 31197730

Group type: EXPERIMENTAL
Intervention: Health system-based tobacco coach (internal care coordination)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: National quitline (external community referral)
Number of subjects: 639

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 639
Study: 27753246

Group type: EXPERIMENTAL
Intervention: Interceed (oxidized regenerated cellulose)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Non‐Interceed (control group)
Number of subjects: 99
Study: 25258197

Group type: EXPERIMENTAL
Intervention: Centrifugal pump
Number of subjects: 58

Group type: COMPARATOR
Intervention: Roller pump
Number of subjects: 58
Study: 23135343

Group type: EXPERIMENTAL
Intervention: Colobreathe dry powder for inhalation (CDPI, one capsule containing colistimethate sodium 1,662,500 IU, twice daily)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Tobramycin inhaler solution (TIS, 300 mg/5 ml, twice daily for three 28-day cycles)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Colobreathe dry powder for inhalation (CDPI)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Tobramycin inhaler solution (TIS)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 380
Study: 21536248

Group type: EXPERIMENTAL
Intervention: Thoracic duct mass ligation during esophagectomy (prevention group)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Esophagectomy without thoracic duct mass ligation (preservation group)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Overall incidence of chylothorax
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Postoperative chylothorax management
Number of subjects: 653
Study: 18047501

Group type: EXPERIMENTAL
Intervention: BoNTA (139 units total; 17 sites/6 muscle groups)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: BoNTA (open-label treatment months 4-6)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: BoNTA
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 16480401

Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg, intravenous, 8-weekly through to week 32)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 12716572

Group type: EXPERIMENTAL
Intervention: Training sessions and written information
Number of subjects: 84

Group type: COMPARATOR
Intervention: Written information only (Control)
Number of subjects: 84
Study: 10855459

Group type: EXPERIMENTAL
Intervention: Cyclandelate 800 mg bid
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 9116778

Group type: EXPERIMENTAL
Intervention: Micronized progesterone (900-1200 mg/day)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 1590931

Group type: EXPERIMENTAL
Intervention: Calcium sodium alginate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Porcine xenograft
Number of subjects: 20
Study: 3897051

Group type: EXPERIMENTAL
Intervention: Sliding screw plate
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sliding nail plate
Number of subjects: 49
Study: 29528704

Group type: EXPERIMENTAL
Intervention: Vitamin D (Cholecalciferol) 50,000 IU in tablet form, monthly, for 1 yr
Number of subjects: 400

Group type: COMPARATOR
Intervention: Vitamin E 400 IU in tablet form, monthly, for 1 yr
Number of subjects: 400
Study: 26652193

Group type: EXPERIMENTAL
Intervention: START (STrAtegies for RelaTives), an eight-session, manual-based coping intervention
Number of subjects: 260

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 260
Study: 24407182

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg every other day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 22268128

Group type: EXPERIMENTAL
Intervention: Vital@Work intervention (VEP + Personal Vitality Coach)
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: High compliance to yoga
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: High compliance to workout sessions
Number of subjects: 730

Group type: COMPARATOR
Intervention: Vital@Work intervention
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: High workout compliance
Number of subjects: 730
Study: 20604918

Group type: EXPERIMENTAL
Intervention: A-Part Gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-treated group
Number of subjects: 60
Study: 17919141

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 5 x 10(9) colony forming units b.i.d. for 12 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 102
Study: 16116007

Group type: EXPERIMENTAL
Intervention: Epidural morphine 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural morphine 3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural morphine 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural saline
Number of subjects: 0
Study: 12183495

Group type: EXPERIMENTAL
Intervention: 6 mg/kg caffeine 1 h preexercise (Precaf)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 6 x 1 mg/kg caffeine every 20 min throughout steady-state (Durcaf)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 x 5 ml/kg Coca-Cola during steady-state and TT (Coke)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeinated, 6% CHO (Coke)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Decaffeinated, 6% CHO (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeinated, 11% CHO (Coke)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Decaffeinated, 11% CHO (Coke)
Number of subjects: 20
Study: 10396166

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Outpatient-based rehabilitation
Number of subjects: 75
Study: 7568623

Group type: EXPERIMENTAL
Intervention: Normal caffeine consumption
Number of subjects: 25

Group type: COMPARATOR
Intervention: Caffeine deprivation
Number of subjects: 25
Study: 2285683

Group type: EXPERIMENTAL
Intervention: levobunolol 0.5%
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study: 7018438

Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine hydrochloride
Number of subjects: 0
Study: 31192699

Group type: EXPERIMENTAL
Intervention: Caressing (hugging)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no caressing)
Number of subjects: 120
Study: 31462110

Group type: EXPERIMENTAL
Intervention: Stereotactic radiofrequency ablation (SRFA)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (non-subcardiac HCC)
Number of subjects: 79
Study: 28228425

Group type: EXPERIMENTAL
Intervention: Prebiotic supplementation (8 g oligofructose-enriched inulin/d)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 42
Study: 26027222

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control
Number of subjects: 88
Study: 24166792

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Low baseline levels of erythrocyte folate
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Other one-carbon metabolism biomarkers
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Baseline levels of biomarkers and changes after 3 months
Number of subjects: 387
Study: 22060248

Group type: EXPERIMENTAL
Intervention: Guided self-help (10-week web-based treatment with weekly therapist support via e-mail)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Unguided self-help (10-week web-based treatment without therapist support)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 76
Study: 19082528

Group type: EXPERIMENTAL
Intervention: Combined therapy (calcium supplement plus menatetrenone)
Number of subjects: 4378

Group type: COMPARATOR
Intervention: Monotherapy (calcium supplement)
Number of subjects: 4378
Study: 18251131

Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg every four hours for 48 hours)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Albumin (8g/L of removed ascites)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Albumin
Number of subjects: 49
Study: 14679443

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 371

Group type: COMPARATOR
Intervention: Ampicillin-sulbactam/amoxicillin-clavulanate
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Linezolid (specifically for infected foot ulcers)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Linezolid (specifically for patients without osteomyelitis)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Linezolid and comparators (inpatients and outpatients)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Linezolid and comparators (oral and intravenous formulations)
Number of subjects: 371
Study: 12055663

Group type: EXPERIMENTAL
Intervention: STW 5
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: STW 5-II
Number of subjects: 186

Group type: COMPARATOR
Intervention: cisapride
Number of subjects: 186
Study: 9931791

Group type: EXPERIMENTAL
Intervention: Identification of parathyroid glands during surgery
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Bilateral conventional subtotal resection
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Extent of the operation and manipulation of the parathyroid glands
Number of subjects: 579
Study: 7646919

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone)
Number of subjects: 59

Group type: COMPARATOR
Intervention: CNOP (cyclophosphamide, mitoxantrone, vincristine and prednisolone)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 59

Group type: COMPARATOR
Intervention: CNOP
Number of subjects: 59
Study: 2692971

Group type: EXPERIMENTAL
Intervention: Fenticonazole (2%) spray
Number of subjects: 100

Group type: COMPARATOR
Intervention: Naftifine (1%) spray
Number of subjects: 100
Study: 413345

Group type: EXPERIMENTAL
Intervention: Stanozolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30561672

Group type: COMPARATOR
Intervention: rVSVDG-ZEBOV-GP vaccine
Number of subjects: 210
Study: 28029409

Group type: EXPERIMENTAL
Intervention: Resveratrol (500 mg/day) for 30 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Caloric restriction (1000 cal/day) for 30 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 48
Study: 25995585

Group type: EXPERIMENTAL
Intervention: Low back pain rehabilitation program + treadmill exercise (30 min, 3.0-3.5 km/h, thrice/week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low back pain rehabilitation program (30 min, thrice/week for 8 weeks)
Number of subjects: 20
Study: 23413415

Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Antidepressant medications
Number of subjects: 92
Study: 21272399

Group type: EXPERIMENTAL
Intervention: 45 g whey protein isolate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 45 g sodium caseinate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 45 g glucose control
Number of subjects: 20
Study: 19581618

Group type: EXPERIMENTAL
Intervention: Shared access to a Web-based, colour-coded diabetes tracker providing monitoring values for 13 diabetes risk factors
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Shared access to a Web-based, colour-coded diabetes tracker
Number of subjects: 511

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 511
Study: 16251993

Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.0 g/kg (placebo)
Number of subjects: 20
Study: 15332386

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (SFC) combination (50/500 microg)
Number of subjects: 6200

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (500 microg)
Number of subjects: 6200

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg)
Number of subjects: 6200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6200

Group type: EXPERIMENTAL
Intervention: SFC, fluticasone propionate, salmeterol, placebo
Number of subjects: 6200
Study: 11164668

Group type: EXPERIMENTAL
Intervention: Topical silver sulfadiazine combined with cerium nitrate (SSD‐CN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical silver sulfadiazine (SSD)
Number of subjects: 60
Study: 9266790

Group type: EXPERIMENTAL
Intervention: Intravenous dipyridamole infusion (0.56 mg/kg over a 4‐minute period) 48 to 96 hours after onset of symptoms
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control group (no test)
Number of subjects: 284
Study: 8492964

Group type: EXPERIMENTAL
Intervention: Droxicam (20 mg/day, orally administered)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tenoxicam (20 mg/day, orally administered)
Number of subjects: 0
Study: 2893634

Group type: EXPERIMENTAL
Intervention: Ro 31-1118
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Flusoxolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prenalterol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30143316

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral nerve block with up to 20mL of 0.3mL.kg‐1 of 0.5% bupivacaine and intravenous tramadol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard management group; up to 3mL of 0.9% saline in the femoral sheath and intravenous tramadol
Number of subjects: 32
Study: 27026442

Group type: EXPERIMENTAL
Intervention: Bilateral implantation of Restor +2.5 D multifocal IOLs
Number of subjects: 103

Group type: COMPARATOR
Intervention: Contralateral implantation of Restor +2.5 D IOL in dominant eye and Restor +3.0 D IOL in fellow eye
Number of subjects: 103
Study: 25453990

Group type: EXPERIMENTAL
Intervention: 20-Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: 1-Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison of 20-Hz rTMS and 1-Hz rTMS
Number of subjects: 18
Study: 23739902

Group type: EXPERIMENTAL
Intervention: Elastic band exercise (60 min, three times per week for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 40
Study: 20593142

Group type: EXPERIMENTAL
Intervention: Magnesium (Mg) supplementation during CABG surgery
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) administered just before the release of the aortic cross clamp
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no Mg supplementation)
Number of subjects: 92

Group type: COMPARATOR
Intervention: NAC untreated group (placebo with dextrose solution)
Number of subjects: 92
Study: 18703812

Group type: EXPERIMENTAL
Intervention: Warfarin (in SPORTIF V)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin (in SPORTIF III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factors influencing stroke risk in SPORTIF V
Number of subjects: 0
Study: 15691565

Group type: EXPERIMENTAL
Intervention: Silicone optic IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Acrylic optic IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Round-edge optic IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Sharp-edge optic IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: PMMA loop IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Polyvinylidene fluoride loop IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Single-piece acrylic haptic IOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: 3-piece PMMA haptic IOL
Number of subjects: 331
Study: 12829674

Group type: EXPERIMENTAL
Intervention: 800 mg/d of PTX and 1,000 U/d of Vit E
Number of subjects: 24

Group type: COMPARATOR
Intervention: PTX plus placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo plus Vit E
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo-placebo
Number of subjects: 24
Study: 11013551

Group type: EXPERIMENTAL
Intervention: Video Interaction Analysis training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 40
Study: 8928439

Group type: EXPERIMENTAL
Intervention: Infrared (lambda = 0.85 microns) laser radiation to the skin
Number of subjects: 0
Study: 1739193

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and diltiazem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 0
Study: 6734709

Group type: EXPERIMENTAL
Intervention: Oral contraceptive steroids
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no oral contraceptive steroids)
Number of subjects: 20
Study: 30161180

Group type: EXPERIMENTAL
Intervention: LED light set to 5000K (higher CCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: LED light set to 3500K (lower CCT)
Number of subjects: 20
Study: 26910661

Group type: EXPERIMENTAL
Intervention: Nonanimal stabilized hyaluronic acid injection
Number of subjects: 25
Study: 23796208

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention including staff training and written breastfeeding procedure
Number of subjects: 110

Group type: COMPARATOR
Intervention: Historical group (no intervention)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Having at least one stress factor during pregnancy
Number of subjects: 110
Study: 22135154

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics (cefazolin 1 g given <30 minutes prior to skin incision)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Intraoperative antibiotics (cefazolin 1 g at cord clamping)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics or intraoperative antibiotics
Number of subjects: 434
Study: 20194915

Group type: EXPERIMENTAL
Intervention: Pregabalin (600 mg/d after titration over 8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 32
Study: 18538052

Group type: EXPERIMENTAL
Intervention: High urinary flow rate (10 mL kg(‐1) h(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low urinary flow rate (3 mL kg(‐1) h(‐1))
Number of subjects: 24
Study: 16041725

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 12801492

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal GP care (Control)
Number of subjects: 60
Study: 10857818

Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified (HSM) intraocular lenses
Number of subjects: 367
Study: 8853141

Group type: EXPERIMENTAL
Intervention: Teflon-coated guidewires with blood exposure for 3 minutes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Teflon-coated guidewires with blood exposure for 5 minutes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Teflon-coated guidewires with blood exposure for 10 minutes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Low-dose systemic administration of heparin (2,500 units)
Number of subjects: 35
Study: 1642831

Group type: EXPERIMENTAL
Intervention: Twice daily radiation plus concomitant chemotherapy with cisplatin and fluorouracil (5-fluorouracil)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Twice daily radiation alone
Number of subjects: 58
Study: 6384073

Group type: EXPERIMENTAL
Intervention: Indoprofen 100 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Indoprofen 200 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Indoprofen 400 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lysine acetylsalicylate (ASA) 500 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lysine acetylsalicylate (ASA) 1500 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Indoprofen
Number of subjects: 75
Study: 31985173

Group type: EXPERIMENTAL
Intervention: Discussion with a male doctor
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Discussion with a female doctor
Number of subjects: 153
Study: 30993748

Group type: EXPERIMENTAL
Intervention: Simtuzumab (combined treatment groups from two phase 2b trials)
Number of subjects: 475
Study: 30407329

Group type: EXPERIMENTAL
Intervention: M72/AS01E
Number of subjects: 240

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 240